Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4 results

Filters applied: . Clear all
Page 1
Management of Acute and Recurrent Pericarditis: JACC State-of-the-Art Review.
Chiabrando JG, Bonaventura A, Vecchié A, Wohlford GF, Mauro AG, Jordan JH, Grizzard JD, Montecucco F, Berrocal DH, Brucato A, Imazio M, Abbate A. Chiabrando JG, et al. Among authors: mauro ag. J Am Coll Cardiol. 2020 Jan 7;75(1):76-92. doi: 10.1016/j.jacc.2019.11.021. J Am Coll Cardiol. 2020. PMID: 31918837 Free article. Review.
Acute pericarditis is generally self-limited and not life-threatening; yet, it may cause significant short-term disability, be complicated by either a large pericardial effusion or tamponade, and carry a significant risk of recurrence. ...
Acute pericarditis is generally self-limited and not life-threatening; yet, it may cause significant short-term disability, be compli …
Low Density Lipoprotein Receptor-Related Protein-1 in Cardiac Inflammation and Infarct Healing.
Potere N, Del Buono MG, Mauro AG, Abbate A, Toldo S. Potere N, et al. Among authors: mauro ag. Front Cardiovasc Med. 2019 Apr 26;6:51. doi: 10.3389/fcvm.2019.00051. eCollection 2019. Front Cardiovasc Med. 2019. PMID: 31080804 Free PMC article. Review.
Additional therapies are therefore warranted to blunt the inflammatory response associated with ischemia and reperfusion and prevent long-term adverse events. Low-density lipoprotein receptor-related protein 1 (LRP1) is a ubiquitous endocytic cell surface receptor with the …
Additional therapies are therefore warranted to blunt the inflammatory response associated with ischemia and reperfusion and prevent long- …
Sacubitril/Valsartan Averts Adverse Post-Infarction Ventricular Remodeling and Preserves Systolic Function in Rabbits.
Torrado J, Cain C, Mauro AG, Romeo F, Ockaili R, Chau VQ, Nestler JA, Devarakonda T, Ghosh S, Das A, Salloum FN. Torrado J, et al. Among authors: mauro ag. J Am Coll Cardiol. 2018 Nov 6;72(19):2342-2356. doi: 10.1016/j.jacc.2018.07.102. J Am Coll Cardiol. 2018. PMID: 30384891 Free article.
CONCLUSIONS: Reperfusion therapy with SAC/VAL or VAL offers robust acute infarct-sparing benefits; however, SAC/VAL treatment offered superior short-term and long-term benefits in preventing MI-induced LV dysfunction compared with VAL. ...
CONCLUSIONS: Reperfusion therapy with SAC/VAL or VAL offers robust acute infarct-sparing benefits; however, SAC/VAL treatment offered superi …
A Preclinical Translational Study of the Cardioprotective Effects of Plasma-Derived Alpha-1 Anti-trypsin in Acute Myocardial Infarction.
Mauro AG, Mezzaroma E, Marchetti C, Narayan P, Del Buono MG, Capuano M, Prestamburgo A, Catapano S, Salloum FN, Abbate A, Toldo S. Mauro AG, et al. J Cardiovasc Pharmacol. 2017 May;69(5):273-278. doi: 10.1097/FJC.0000000000000474. J Cardiovasc Pharmacol. 2017. PMID: 28195949
Finally, we tested whether a single dose at reperfusion was sufficient to maintain a benefit in the longer term (7 days). Infarct size was measured by 3 different and independent methodologies: pathology, plasma levels of troponin I, and wall motion abnormalities at echoca …
Finally, we tested whether a single dose at reperfusion was sufficient to maintain a benefit in the longer term (7 days). Infarct siz …